Recombinant hirudin, CGP 39393 (Revasc), is more effective than enoxaparin as prophylaxis of thromboembolic complications in patients undergoing total hip replacement - Erikson, BI; Mouret, P; Kälebo, P; Baue, M; Ekman, S; Lindbrat, S; Bach, D; Close, P (Haemostasis, 1996)